Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response
Mahmoud M. Iravani, Mona Sadeghian, Clement C. M. Leung, Banu C. Tel, Sarah Rose, Anthony H. Schapira, Peter Jenner
Research output: Contribution to journal › Article › peer-review
29Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response'. Together they form a unique fingerprint.